divest
-
Recon
Implanet Announces the Planned Divestment of Its Knee Prosthesis to Focus on Its Spine Business
Initiation of exclusive negotiations with the Menix Group’s SERF companyStrategic refocus to become a benchmark player in Spine surgery September…
Read More » -
Hospitals
Aetna To Divest Medicare Plans And May Exit Obamacare
AUG 2, 2016 – Bruce Japsen Aetna and Humana will sell certain Medicare Advantage assets to Molina Healthcare as the insurers…
Read More » -
Financial
J&J Said to Be in Talks on Sale of Cordis, With Cardinal Leading
by Cynthia Koons and Ed Hammond (Bloomberg) — Johnson & Johnson, the world’s biggest maker of health-care products, is in talks to sell…
Read More » -
Extremities
FTC Biting at Wright and Tornier’s Ankles
Walter Eisner • Wed, February 4th, 2015 Wright Medical Group, Inc. has received a “Second Request” from the Federal Trade…
Read More » -
Recon
Zimmer may have to divest Uni-compartmental Knees and Shoulders to do the Biomet deal
Walter Eisner • Mon, November 24th, 2014 The European Commission was supposed to make a decision on the ZimmerBiomet deal…
Read More » -
Integra Lifesciences Expresses Interest to Divest Spine Business
BY ANDREW VAHRADIAN, AUGUST 27, 2014 Last week, Glenn Coleman the CFO of Integra Lifesciences, expressed to analysts that the…
Read More » -
Recon
Symmetry Medical Divests UK Based Clamonta Ltd. Subsidiary
WARSAW, Ind., May 22, 2014 (GLOBE NEWSWIRE) — Symmetry Medical Inc. (NYSE:SMA), a leading global source of innovative medical device solutions, including surgical instruments,…
Read More » -
Sports Medicine
Orthofix sells Breg sports medicine unit to PE firm for $158M cash
April 24, 2012 by MassDevice staff Orthofix sells its sports medicine subsidiary Breg Inc. to private equity subsidiary Breg Acquisition Corp. for…
Read More » -
Spine
Medtronic indicates it’s considering selling its spine unit
By Christopher Snowbeck csnowbeck@pioneerpress.com Posted: 02/21/2012 12:01:00 AM CST Updated: 02/21/2012 09:36:39 PM CST Another quarter of weak sales…
Read More » -
Biologics
Geron Selling Off Embryonic Stem Cell Technology
After nearly $450 million of equity raised and a record breaking $40 million FDA submission, Geron is throwing in the…
Read More » -
SNN spins out biologics unit in JV with Essex Woodlands
British orthopedic titan Smith & Nephew (NYSE:SNN) shuffled its business deck yet again with the spinout of its biologics and…
Read More »